Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
07/2012
07/03/2012US8211093 Data storage for an infusion pump system
07/03/2012US8211092 Containment device with multi-layer reservoir cap structure
07/03/2012US8211091 Method and apparatus for charging pump with local anesthetic
07/03/2012US8211067 Mechanical system
07/03/2012US8211061 Intelligent remote-controlled portable intravenous injection and transfusion system
07/03/2012CA2665567C Stable formulations
07/03/2012CA2599614C Use of a volatile rhinological effective composition on fibrous tissues to provide a sensation of sinusoidal relieve
07/03/2012CA2589993C Room-temperature stable dronabinol formulations
07/03/2012CA2567023C Compositions and methods for bone formation and remodeling
07/03/2012CA2538419C Use of ciclesonide for the treatment of respiratory diseases
07/03/2012CA2526202C Compositions for treating infection in cattle and swine
07/03/2012CA2510263C Preparation of sterile aqueous suspensions comprising micronised crystalline active ingredients for inhalation
07/03/2012CA2505639C System and method for initiating and maintaining continuous, long-term control of a concentration of a substance in a patient using a feedback or model-based controller coupled toa single-needle or multi-needle intradermal (id) delivery device
07/03/2012CA2500713C Photokinetic delivery of biologically active substances using pulsed incoherent light
07/03/2012CA2493464C Microcapsules with modified release of active principles with low solubility for oral delivery
07/03/2012CA2492789C Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate
07/03/2012CA2484140C Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units
07/03/2012CA2471041C Compositions and methods for enhancing corticosteriod delivery
07/03/2012CA2468958C Pulmonary delivery of aminoglycosides
07/03/2012CA2452015C Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
07/03/2012CA2413164C Process for producing isomaltose and use thereof
06/2012
06/28/2012WO2012088210A2 Methods and compositions for wound treatment
06/28/2012WO2012088033A2 Novel pharmaceutical composition
06/28/2012WO2012087927A1 Novel preparation of an enteric release system
06/28/2012WO2012087823A2 Ph-induced silk fibroin gels and uses thereof
06/28/2012WO2012087669A1 Pill catchers
06/28/2012WO2012087606A1 A drug eluting patch for the treatment of localized tissue disease or defect
06/28/2012WO2012087517A2 Cosmetic films
06/28/2012WO2012087377A1 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
06/28/2012WO2012087326A1 Fluid compositions comprising a structuring agent
06/28/2012WO2012087257A2 Oral dosage form comprising imatinib and production of said oral dosage form
06/28/2012WO2012087256A2 Pharmaceutical capsule formulations
06/28/2012WO2012087094A1 Inhalable pharmaceutical composition for treating asthma by airborne administration by means of an emulation aerosol suction unit
06/28/2012WO2012087062A2 Sustained-release polymeric microparticles containing poorly water-soluble drug and method for preparing the same
06/28/2012WO2012087051A2 Microparticles containing physiologically active peptide, method for preparing the same, and pharmaceutical composition comprising the same
06/28/2012WO2012087047A2 Percutaneous absorption preparation containing rivastigmine
06/28/2012WO2012086760A1 Disinfectant
06/28/2012WO2012086712A1 Elution-controlled oral liquid preparation
06/28/2012WO2012086593A1 Viscous nutritional composition
06/28/2012WO2012085933A1 Pharmaceutical compositions of tenecteplase
06/28/2012WO2012085919A2 Method and system for drug delivery
06/28/2012WO2012085888A2 Polyelectrolyte complex, process for its manufacture and use thereof
06/28/2012WO2012085847A2 Triggered polymer viscous pill and methods of using the same
06/28/2012WO2012085657A2 Tamper resistant solid oral dosage forms
06/28/2012WO2012085656A2 Encased tamper resistant controlled release dosage forms
06/28/2012WO2012085609A1 Treatment of osteoarthritis by continuous intra-articular injection of alginate gel
06/28/2012WO2012085559A1 Antibacterial or anti-acne formulations containing usnic acid or an usnate and a metal salt
06/28/2012WO2012085483A1 Dermatological foams obtained from a gel or suspension containing benzoyl peroxide
06/28/2012WO2012085481A1 Dermatological foams obtained from a gel or suspension containing adapalene
06/28/2012WO2012085480A1 Dermatological foams obtained from a gel or suspension containing a combination of adapalene and benzoyl peroxide
06/28/2012WO2012085318A1 Lipid nanoparticles for treating ocular diseases
06/28/2012WO2012085304A1 Phosphomycin pharmaceutical composition
06/28/2012WO2012085284A2 High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
06/28/2012WO2012085249A2 Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts
06/28/2012WO2012085236A1 Solid retard formulations based on solid dispersions
06/28/2012WO2012085197A1 Pharmaceutical composites of poorly water soluble drugs and polymers
06/28/2012WO2012085194A1 Compressed solid dosage forms
06/28/2012WO2012085185A1 Aqueous solution of ambroxol
06/28/2012WO2012085171A2 Pharmaceutical compositions of pyridinium and quinolinium derivatives
06/28/2012WO2012085160A1 Formulations of antiparasitic agents for topical administration to swine
06/28/2012WO2012085071A1 Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
06/28/2012WO2012085043A2 Rapidly disintegrating, solid coated dosage form
06/28/2012WO2012085018A1 Pharmaceutical composition containing active vegetable substances
06/28/2012WO2012084969A1 Adhesive composition containing rotigotine and transdermal therapeutic system comprising the adhesive composition
06/28/2012WO2012084951A1 Enhanced immune response in bovine species
06/28/2012WO2012084126A2 Formulation of lacosamide
06/28/2012WO2012083947A1 Chewing gum composition comprising cross-linked polyacrylic acid
06/28/2012WO2012083801A1 Streoidal anti-progesterone composition, preparation method therefor, and use thereof
06/28/2012WO2012083571A1 Carotenoid oil suspension with high bioavailability and preparation method thereof
06/28/2012WO2012083548A1 Administration method of citicoline for treating stroke
06/28/2012WO2012083532A1 Method for ultrasound controlled releasing medicine-carrying contrast micro-bubbles and monitor-imaging thereof and method for estimating damaged quantity of microbubbles
06/28/2012WO2012083493A1 Medicinal composition
06/28/2012WO2012061259A3 Novel low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
06/28/2012WO2012060793A3 Process for the preparation of cefdinir formulations
06/28/2012WO2012060789A3 Production method for cefdinir formulations
06/28/2012WO2012057525A3 Liquid formulations of long acting interferon alpha conjugate
06/28/2012WO2012054717A3 Detecting and treating solid tumors through selective disruption of tumor vasculature
06/28/2012WO2012053785A3 Sustained-release pellets containing tacrolimus as an active ingredient
06/28/2012WO2012051204A3 Antimicrobial formulations that aid in wound healing
06/28/2012WO2012045072A3 Sugar-based dispersion
06/28/2012WO2012040082A3 Antidiabetic solid pharmaceutical compositions
06/28/2012WO2012036442A3 Adhesive composition comprising tannin, polyethylene glycol, and water, lower alcohol or mixture thereof
06/28/2012WO2012013331A3 Capsules of active pharmaceutical ingredients and polyunsaturated fatty acids for the treatment of prostate diseases
06/28/2012WO2012007584A3 Composition for the treatment of superficial lesions
06/28/2012WO2011159491A3 Controlled release levetiracetam formulations
06/28/2012WO2011156481A3 Formulations including amiodarone and salts thereof and methods of their manufacture and use
06/28/2012WO2011154725A3 Compositions comprising buprenorphine
06/28/2012WO2011151418A3 Nanosuspension formulation comprising a polydimethylsiloxane hydrophobic phase
06/28/2012WO2011150144A3 Aqueous formulations for coating microneedle arrays
06/28/2012WO2011141108A3 Dosage forms for cineole
06/28/2012WO2011133685A9 Nanoparticle targeting to ischemia for imaging and therapy
06/28/2012WO2011130716A3 A nanostructures containing vitamin b12 for facilitated delivery of drugs across biological barriers
06/28/2012WO2011128630A3 Anti-abuse gelled pharmaceutical compositions
06/28/2012WO2011051033A3 Encapsulation of reactive components for 1-k systems using coaxial dies
06/28/2012US20120165795 Therapeutic agent reservoir delivery system
06/28/2012US20120165793 Pill Catchers
06/28/2012US20120165782 pharmaceutical composition of an iontophoresis
06/28/2012US20120165363 Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders
06/28/2012US20120165361 Drug coating providing high drug loading and methods for providing the same
06/28/2012US20120165359 Opioid Agonist/Antagonist Combinations
1 ... 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 ... 2991